Showing results (261-270 of 688) with videos related to

Sort By:
Pageof 69
Arthritis Care & Research|January 13, 2015
Continued participation in a ten-year tight control treat-to-target study in rheumatoid arthritis: why keep patients doing their best?Iris M Markusse, Linda Dirven, K Huub Han, et al.
Rheumatology (Oxford, England)|October 8, 2014
IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalitiesDiahann T S L Jansen, Marjolijn Hameetman, Jeroen van Bergen, et al.
Plos One|July 16, 2014
Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritisJeroen N Stoop, Bi-Sheng Liu, Jing Shi, et al.
Rheumatology (Oxford, England)|October 1, 2016
Older age is associated with more MRI-detected inflammation in hand and foot jointsWouter P Nieuwenhuis, Lukas Mangnus, Hanna W van Steenbergen, et al.
RMD Open|April 22, 2022
Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestationsRory C Monahan, Michelle D van den Beukel, Nicole V Borggreven, et al.
Annals of the Rheumatic Diseases|April 11, 2014
Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRIHanna W van Steenbergen, Jessica A B van Nies, Tom W J Huizinga, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
IFN-associated B cell hyperactivity is highly enriched in SLE patients harboring Sm/RNP antibodiesH J van Dooren, Y Atisha-Fregoso, A L Dorjée, et al.
Journal of Autoimmunity|September 29, 2024
Autoreactive B cells remain active despite clinical disease control in rheumatoid arthritisSam Neppelenbroek, Nienke J Blomberg, Arieke S B Kampstra, et al.
Arthritis and Rheumatism|May 29, 2007
A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritisJudith A M Wessels, Sjoerd M van der Kooij, Saskia le Cessie, et al.
Annals of the Rheumatic Diseases|January 22, 2013
Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study)Jill van Aken, Lotte Heimans, Henrike Gillet-van Dongen, et al.
Pageof 69